Epigral Ltd Board Meeting on July 27, 2026 for Un-audited Financial Results

Epigral Ltd has announced that its Board of Directors will convene on July 27, 2026. The primary agenda item for this meeting is to consider and approve the un-audited financial results for the first quarter ended June 30, 2026. Both standalone and consolidated results will be reviewed, along with the statutory auditors' limited review report. The meeting will also address any other business as permitted by the Chair. This announcement serves to inform the company's shareholders and members.